Rise in Prevalence of Chronic & Acute Diseases Anticipated to Drive Global Biologics Market over the Forecast Period: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Biologics are substances derived from animals, human, and microorganisms through biotechnology. They include genes that control production of vital proteins, proteins that control the action of other proteins & cellular processes, modify human hormones, or cells that produce products that suppress or activate components of an immune system. They are used for treatment of numerous diseases & conditions such as rheumatoid arthritis, ulcerative colitis, and other autoimmune diseases. Some common side effects include weakness, chills, allergic reactions, nausea, diarrhea, itching, vomiting, injection side reaction, constipation, cough, headache, fever, shortness of breath, fever, dizziness and others. According to study, “Global Biologics Market Research Report: by Product (Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, Gene Therapy, Others), by Disease Indication (Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, Cancer, Diabetes, Others), by Manufacturing (In-house, Sourced), and Region – Forecast to 2023” the key companies operating in the global biologics market are AbbVie, Inc., AstraZeneca, Pfizer Inc., Bayer AG, GlaxoSmithKline Plc., Amgen, Sanofi, Novartis AG, Eli Lilly and Company, F. Hoffman-La Roche AG. Based on product type, biologics market is segmented into vaccines, gene therapy, interleukins, growth factors and monoclonal antibody. Monoclonal antibody segment includes human, humanized, murine and chimeric. Vaccines segment holds major share in market owing to growth in adoption of vaccines in the treatment of infectious diseases. Monoclonal segment is expected to dominate the market due to its importance in the development of personalized medication during the forecast period. Based on disease indication, market is segmented into psoriasis or psoriatic arthritis, cancer, diabetes, Crohn’s disease, rheumatoid arthritis, ulcerative colitis, ankylosing spondylitis, cardiovascular diseases and juvenile idiopathic arthropathy. In addition, based on manufacturing, market is segmented into sourced and in-house manufacturing. The biologics market is driven by growth in healthcare expenditure, rise in prevalence of chronic & acute diseases, increase in capital investment from key market players, growth in demand & higher acceptability for innovative therapies, loss of patent exclusivity of the leading biologic drugs, rise in awareness about benefits of biologics in treating conditions, increase in geriatric population and growth in advancements in biologics. However, rise in control and cost for accessing biologics and stringent regulatory process & initial high capital investment may impact the market. Moreover, growth in therapeutical applications and increase in research & development (R&D) activities in the field of pharmaceutical industries are major opportunities for market. Based on geography, the North-American region holds major share in biologics market owing to growth in competition in the healthcare sector and rise in biotechnology sector in the region. The European and Asian-Pacific regions are predictable to witness higher growth rate due to surge in prevalence of cancer & diabetes and growth in government support over the forecast period. In upcoming years, it is projected that the market will be reached at rapid pace as a result of strong growth prospects of the nascent biotechnology sector and rise in realization of the efficacy of biologics in treating stubborn conditions for instance diabetes, rheumatoid arthritis, and cancer during the forecast period. The global is growing at a CAGR of 6.95% and is anticipated to reach the value of US $285,520.4 million by the end of the forecast period (2018-2023). For more information on the research report, refer to below link:- Global Biologics Market Related Report:- Global Next-Generation Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: AbbVie Biologics Market Size, Africa Biologics Market, Americas Biologics Market, Amgen Biologics Market Sales, Asia Pacific Biologics Market, AstraZeneca Biologics Market Shares, Australia Biologics Market, Bayer Biologics Market Size, Biologics Industry In Global, Biologics Market In Global, Canada Biologics Market, China Biologics Market, Eli Lilly Biologics Market Shares, Europe Biologics Market, F. Hoffman-La Roche Biologics Market Shares, France Biologics Market, Germany Biologics Market, GlaxoSmithKline Biologics Market Revenue, Global Ankylosing Spondylitis Biologics Market, Global Biologics Humanized Market, Global Biologics Industry, Global Biologics Industry Research Report, Global Biologics Market, Global Biologics Market Analysis, Global Biologics Market Competition, Global Biologics Market Forecast, Global Biologics Market Future Outlook, Global Biologics Market Growth, Global Biologics Market Major Players, Global Biologics Market Research Report, Global Biologics Market Revenue, Global Biologics Market Shares, Global Biologics Market Size, Global Biologics Market Trends, Global Cancer Biologics Market, Global Cardiovascular Diseases Market, Global Chimeric Biologics Market, Global Diabetes Biologics Market, Global Gene Therapy Biologics Market, Global Human Biologics Market, Global In house Biologics Market, Global Interleukins Biologics Market, Global Juvenile Idiopathic Arthritis Biologics Market, Global Monoclonal Antibody Market, Global Murine Biologics Market, Global Outsourced Biologics Market, Global Psoriatic Arthritis Biologics Market, Global Rheumatoid Arthritis Biologics Market, Global Ulcerative Colitis Biologics Market, Global Vaccines Biologics Market, Globaler Biologics-Markt, India Biologics Market, Industry Research Report Of Global Biologics, Italy Biologics Market, Japan Biologics Market, Market Research Report Of Global Biologics, Mercado mundial de productos biológicos, Middle East Biologics Market, North America Biologics Market, Novartis AG Biologics Market Revenue, Pasar Biologi Global, Pfizer Biologics Market Revenue, Sanofi Biologics Market Size, South America Biologics Market, South Korea Biologics Market, Spain Biologics Market, UK Biologics Market, US Biologics Market, Western Europe Biologics Market, Глобальный рынок биопрепаратов, سوق البيولوجيا العالمية, 世界の生物製剤市場, 全球生物制品市场, 세계 생물 제제 시장